Your browser doesn't support javascript.
loading
Potential human transmission of amyloid ß pathology: surveillance and risks.
Lauwers, Elsa; Lalli, Giovanna; Brandner, Sebastian; Collinge, John; Compernolle, Veerle; Duyckaerts, Charles; Edgren, Gustaf; Haïk, Stéphane; Hardy, John; Helmy, Adel; Ivinson, Adrian J; Jaunmuktane, Zane; Jucker, Mathias; Knight, Richard; Lemmens, Robin; Lin, I-Chun; Love, Seth; Mead, Simon; Perry, V Hugh; Pickett, James; Poppy, Guy; Radford, Sheena E; Rousseau, Frederic; Routledge, Carol; Schiavo, Giampietro; Schymkowitz, Joost; Selkoe, Dennis J; Smith, Colin; Thal, Dietmar R; Theys, Tom; Tiberghien, Pierre; van den Burg, Peter; Vandekerckhove, Philippe; Walton, Clare; Zaaijer, Hans L; Zetterberg, Henrik; De Strooper, Bart.
Affiliation
  • Lauwers E; VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium; Department of Neurosciences, Leuven Brain Institute, KU Leuven, Leuven, Belgium.
  • Lalli G; UK Dementia Research Institute, University College London, London, UK.
  • Brandner S; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London National Health Service Foundation Trust, London, UK.
  • Collinge J; Medical Research Council Prion Unit at UCL, Institute of Prion Diseases, University College London, London, UK.
  • Compernolle V; Blood Services, Belgian Red Cross-Flanders, Mechelen, Belgium; Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Duyckaerts C; Institut du Cerveau et de la Moelle épinière, Sorbonne University, INSERM, CNRS UMR, Paris, France; Laboratoire de Neuropathologie Raymond Escourolle, Hôpital de la Pitié-Salpêtrière, Assistance Publique- Hôpitaux de Paris, Paris, France.
  • Edgren G; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Södersjukhuset, Stockholm, Sweden.
  • Haïk S; Institut du Cerveau et de la Moelle épinière, Sorbonne University, INSERM, CNRS UMR, Paris, France; Laboratoire de Neuropathologie Raymond Escourolle, Hôpital de la Pitié-Salpêtrière, Assistance Publique- Hôpitaux de Paris, Paris, France; Cellule Nationale de Référence des maladies de Creutzfeldt-Ja
  • Hardy J; UK Dementia Research Institute, University College London, London, UK; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, University College London, London, UK;
  • Helmy A; Department of Clinical Neuroscience, Division of Neurosurgery, University of Cambridge, Cambridge, UK.
  • Ivinson AJ; UK Dementia Research Institute, University College London, London, UK.
  • Jaunmuktane Z; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK; Queen Square Brain Bank for Neurological Disorders, Queen Square Institute of Neurology, University College London, London, UK; Division of Neuropathology, National Hosp
  • Jucker M; Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases, Tübingen, Germany.
  • Knight R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK; National Creutzfeldt-Jakob Disease Research and Surveillance Unit, Western General Hospital, Edinburgh, UK.
  • Lemmens R; VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium; Department of Neurosciences, Leuven Brain Institute, KU Leuven, Leuven, Belgium; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
  • Lin IC; UK Dementia Research Institute, University College London, London, UK.
  • Love S; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Mead S; Medical Research Council Prion Unit at UCL, Institute of Prion Diseases, University College London, London, UK.
  • Perry VH; UK Dementia Research Institute, University College London, London, UK.
  • Pickett J; Alzheimer's Society, London, London, UK; Epilepsy Research UK, London, UK.
  • Poppy G; Biological Sciences, University of Southampton, Southampton, UK.
  • Radford SE; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
  • Rousseau F; VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Routledge C; Alzheimer's Research UK, Cambridge, UK.
  • Schiavo G; UK Dementia Research Institute, University College London, London, UK; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Schymkowitz J; VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Selkoe DJ; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA.
  • Smith C; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Thal DR; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Theys T; Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium.
  • Tiberghien P; Etablissement Français du Sang, La Plaine St Denis, France; Unité Mixte de Recherche, INSERM, Université de Franche-Comté, Besançon, France.
  • van den Burg P; European Blood Alliance, Brussels, Belgium; Department of Transfusion Medicine, Sanquin, Amsterdam, Netherlands.
  • Vandekerckhove P; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Blood Services, Belgian Red Cross-Flanders, Mechelen, Belgium.
  • Walton C; Alzheimer's Society, London, London, UK; Multiple Sclerosis International Federation, London, UK.
  • Zaaijer HL; Department of Blood-borne Infections, Sanquin, Amsterdam, Netherlands.
  • Zetterberg H; UK Dementia Research Institute, University College London, London, UK; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Swed
  • De Strooper B; VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium; Department of Neurosciences, Leuven Brain Institute, KU Leuven, Leuven, Belgium; UK Dementia Research Institute, University College London, London, UK. Electronic address: b.strooper@ukdri.ucl.ac.uk.
Lancet Neurol ; 19(10): 872-878, 2020 10.
Article de En | MEDLINE | ID: mdl-32949547
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Surveillance de la population / Peptides bêta-amyloïdes / Maladies neurodégénératives Type d'étude: Etiology_studies / Risk_factors_studies / Screening_studies Limites: Animals / Humans Langue: En Journal: Lancet Neurol Sujet du journal: NEUROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: Belgique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Surveillance de la population / Peptides bêta-amyloïdes / Maladies neurodégénératives Type d'étude: Etiology_studies / Risk_factors_studies / Screening_studies Limites: Animals / Humans Langue: En Journal: Lancet Neurol Sujet du journal: NEUROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: Belgique